市場調查報告書
商品編碼
1518337
質譜市場:依產品、技術、應用和最終用戶劃分 -2030年全球預測Mass Spectrometry Market by Offering Technology Application End User - Global Forecast to 2030 |
到2030年,質譜市場預計將達到 104 億美元,2023年至2030年的年複合成長率為 8.3%。
本報告成功地進行了廣泛的二級和一級研究以及對市場情景的詳細分析,提供了對關鍵行業驅動因素、限制因素、機會和挑戰的分析。
該市場的成長是由質譜技術的進步、對食品安全的日益關注、質譜應用的增加、製藥和生物技術公司研發支出的增加以及質譜儀的高可靠性和靈敏度所推動的。然而,高昂的設備成本限制了該市場的成長。新興市場日益採用質譜儀,這對於在該市場運營的公司來說是一個重大機會。然而,缺乏熟練的專業人員是影響該市場成長的挑戰。此外,攜帶式質譜儀的日益普及是質譜市場的一個顯著趨勢。
Mass Spectrometry Market Size, Share, Forecast, & Trends Analysis by Offering [Instrument, Software], Technology [Quadrupole, LC MS, Ion Trap, GC MS, Time of Flight, MALDI], Application [Impurity, Clinical Testing], End User - Global Forecast to 2030
The mass spectrometry market is projected to reach $10.4 billion by 2030 at a CAGR of 8.3% from 2023 to 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.
The growth of this market is driven by advancements in mass spectrometry technology, increasing food safety concerns, increasing applications of mass spectrometry, increasing R&D expenditure by pharmaceutical and biotechnology companies, and the high reliability and sensitivity of mass spectrometers. However, the high costs of instruments restrain the growth of this market. The rising adoption of mass spectrometers in emerging markets is a significant opportunity for the players operating in this market. However, the lack of skilled professionals is a challenge impacting the growth of this market. Additionally, the rising adoption of portable mass spectroscopy devices is a prominent trend in the mass spectrometry market.
The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the mass spectrometry market are Agilent Technologies, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Waters Corporation (U.S.), Perkin Elmer Inc. (U.S.), INFICON Holding AG (Switzerland), Pfeiffer Vacuum GmbH (Germany), LECO Corporation (U.S.), Rigaku Corporation (Japan), Shimadzu Corporation (Japan), SCIEX (a subsidiary of Danaher Corporation) (U.S.), LECO CORPORATION (U.S.), and Advion, Inc. (U.S.).
Based on offering, in 2023, the instrument segment is expected to account for the largest share of the mass spectrometry market. The segment's large share is attributed to the instruments' large-scale analysis capabilities and capacity to study several molecules from the same or different structural family and detect specific metabolites of disease.
Based on technology, in 2023, the quadrupole mass spectrometry segment is expected to account for the largest share of the mass spectrometry market. The large share of the segment is attributed to the benefits offered by quadrupole mass analyzers in targeted and quantitative applications and quadrupole mass spectrometry's use in measuring one or more ions in a mixture. Furthermore, quadrupole mass spectrometry is fast, simple, and reliable and does not require a high vacuum.
Based on application, in 2023, the drug metabolism testing segment is expected to account for the largest share of the mass spectrometry market. The large market share of this segment is attributed to the increasing applications of mass spectrometry in drug testing, increasing pharmaceutical and biotechnology research, and the high usage of mass spectrometers in target validation.
Based on end user, in 2023, the pharmaceutical & biotechnology industry segment is expected to account for the largest share of the mass spectrometry market. The large market share of this segment is attributed to the increasing role of mass spectrometry in the drug discovery and development pipeline, the increasing adoption of mass spectrometry in metabolomics, proteomics, and analysis of clinical tissue samples, and mass spectrometers' ability to determine pharmacokinetic properties and compound structures.
An in-depth analysis of the geographical scenario in the mass spectrometry market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the mass spectrometry market. Further, in 2023, the U.S. is expected to account for the major share of the mass spectrometry market in North America. The large share of this market is primarily attributed to the increase in R&D expenditures in the pharmaceutical & biotechnology industries, favorable government initiatives supporting mass spectrometry-based research, and the high adoption of advanced technologies.
Mass Spectrometry Market Assessment-by Offering
Mass Spectrometry Market Assessment-by Technology
Mass Spectrometry Market Assessment-by Application
Note: Other applications include pesticide residue analysis, isotope ratio determination, protein identification, and carbon dating.
Mass Spectrometry Market Assessment-by End User
Note: Other end users include forensics, and the nutraceuticals and cosmeceutical industries.
Mass Spectrometry Market Assessment-by Geography